Management and Development
CEO and Lead Developer. Ivaylo blends experience from cancer genetics with a passion for software development. He did a PhD in molecular genetics at Stockholm University and did his post-doc in cancer genetics at Uppsala University before co-founding Oncodia.
Core Developer. Marina has a MSc in bioinformatics from Uppsala University with a focus on the quality control of next-generation sequencing data. After successful translation of her NGS experience from academia to the Oncodia’s team, Marina dedicated to the core development and building of the software production standards in the company.
Regulatory Implementation Manager and Core Developer. Tom has a MSc in molecular biotechnology engineering from Uppsala University, and a degree in computer science from Göteborg University. He has experience from software development in different sectors, such as the stock exchange (Syncom Financial Systems), electricity market (ABB), biotech (Biacore AB) and somatic mutation calling (UU).
Production Manager ExScale product line. Linnea has extensive knowledge in the field of nucleic acid extractions from a variety of biological sources. She got her MSc from Uppsala University in the field of molecular-/cell biology and has since worked in both pharmaceutical industry as well as university settings. Linnea joined Oncodia following the acquisition of ExScale Biospecimen Solutions in late 2019, and is now responsible for production and development of NGEx products.
Karin Hartman Lindgren
Chief Operating Officer. Karin has a MCs in Biomedicine and a BA in Financial accounting from Uppsala University. With training in both business administration and biomedicine, Karin brings important competence in business and enterprise in the life science sector. She has broad experience in DNA and RNA extraction from tumors and possesses extensive knowledge in the field of molecular diagnostics. Karin has experience from manufacturing, development, and sales and marketing in start-up companies in the medical device industry.
Board of Directors
is the Chairman of Oncodia. He brings 40 years of leadership experience from the medical device industry, including board roles in 15 companies in Sweden, Germany and the US. He was co-founder and Chairman of the publicly traded companies RaySearch and CEO of C-Rad, and is currently Chairman of Pharmacolog AB. He is also Chairman of Nolsterby Invest AB.
CEO of Medicon Village Innovation AB, has experience from international sales, marketing, product management and development from start-up, mid-size and enterprise companies in the medical device industry. She is Chairman of ProstaLund AB, and Board Member of Glycorex Transplantation AB.
Professor of Tumor Genetics at Uppsala University. He pioneered exome sequencing in cancer and the science powering Oncodia’s products was developed in his group at Uppsala University.
Investment manager at Uppsala University Holding AB. Mateo is a business developer and investment professional with 15 years of experience of academic startups, and has been involved in the strategic and operational management of several successful Uppsala University spin-offs.
Principal Investigator and Associate Professor at Temasek Life Sciences Laboratory, Singapore. Ian is a lawyer turned scientist and has co-founded Entopsis LLC (USA) and Pathnova Laboratories Pte Ltd (Singapore).